View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, July 11 (HealthDay News) -- About half of a subgroup of patients with multiple sclerosis have autoantibodies to a potassium channel in the brain, according to a study published in the July 12 issue of the New England Journal of Medicine.
To identify the target of the immune response in multiple sclerosis, Rajneesh Srivastava, from the Technische Universität in Munich, Germany, and colleagues screened serum immunoglobulin G (IgG) from a subgroup of patients with multiple sclerosis who displayed specific binding of IgG to glial cells. Results were validated in other groups of patients with multiple sclerosis.
The researchers found that the membrane protein ATP-sensitive inward rectifying potassium channel (KIR4.1) was the target of the IgG autoantibodies. In the combined datasets analyzed, antibodies to KIR4.1 were present in 46.9 percent of patients with multiple sclerosis, 0.9 percent of patients with other neurological diseases, and no healthy individuals. These antibodies bound to KIR4.1 on the first extracellular loop. Following injection of KIR4.1 serum IgG from multiple sclerosis patients into the cisternae magnae of mice there was loss of KIR4.1 expression, expression of glial fibrillary acidic protein was altered in astrocytes, and the complement cascade was activated where KIR4.1 was expressed in the cerebellum.
"In summary, putting aside a priori assumptions in the search for autoantigens in multiple sclerosis, these investigators took an unbiased approach that resulted in the identification of an unexpected but plausible antigenic target," write the authors of an accompanying editorial. "The specific role of antibodies to KIR4.1 in the pathogenesis of multiple sclerosis awaits further definition."
Several authors disclosed financial relationships with pharmaceutical and biotechnology companies.
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Find in-depth content on major issues provided by leading companies in partnership with NursingCenter.com
BD Safety Beyond Needlestick Prevention Learning Center
Sponsored by BD Medical
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top